Scientific Background and Achievements

The guest, Kay Christopher Garcia, is a structural immunologist and biochemistry professor at Stanford University, recognized for his pivotal structural discoveries that have transformed the understanding of immune receptors. His research has significant implications for developing new treatments for cancer and autoimmune diseases. He has co-founded several startups such as Synthokine, which focuses on custom-designed cytokine drugs, and ALX Oncology, which explores cancer cells' signals. Garcia’s recent accolades include the Max Cooper Prize in Immunology, highlighting the impact of his pioneering work in the field.